UCA1 and myeloid sarcoma: TGF-β has a role in the inflammatory condition and acts as an anti-inflammatory factor to inhibit Th1 and Th17 cells (127), so upregulation of GAS8-AS1 resulting in the downregulation of UCA1 and reduced TGF-β might cause progression and aggregate MS.